-
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart FailureKN Bachmann, DK Gupta , M Xu et al. -
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future DirectionsHsu JJ, Ziaeian B, Fonarow GC.
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart FailureESJ Tan, S-P Chan, O-W Liew et al.
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators.
-
Mechanical circulatory support devices in advanced heart failure: 2020 and beyondJL Vieira, HO Ventura, MR Mehra et al.
-
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFMartinez FA, Serenelli M, Nicolau JC et al.
-
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT StudyJanuzzi JL Jr, Richards AM.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
